Observational study / 2024
Vitamin B12 deficiency was misdiagnosed as myelodysplastic syndrome in two patients who responded to vitamin B12 supplementation.
Two patients initially presented with pancytopenia and normal vitamin B12 levels, leading to a bone marrow biopsy-based diagnosis of myelodysplastic syndrome (MDS). Further testing identified elevated serum methylmalonic acid (MMA) levels, which revised their diagnosis to vitamin B12 deficiency. Both patients improved following adequate vitamin B12 supplementation.
Shows an association, not proof of cause and effect.
- Study type
- Case series
- Who was studied
- Two patients presenting with pancytopenia
- What was measured
- Diagnosis and response to vitamin B12 supplementation
THE PAPER
Unmasking Vitamin B12 Deficiency Misdiagnosed as Myelodysplastic Syndrome.
Jamil M, Nasser Z, Jamil D, Sheqwara JZ. Case Rep Hematol, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.